Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 3736 AL 3750

The Importance of Dopamine Deficiency Evaluation in Non-Alzheimer Disease Dementias

Alkharisi B, Dostzada K, Kaur H, Kumar M, Wei JY, Azhar G.

Am J Case Rep. 2023 Apr 5;24:e938344. doi: 10.12659/AJCR.938344.

Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease

Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team.

Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.

Dissecting the neurovascular unit in physiology and Alzheimer's disease: Functions, imaging tools and genetic mouse models

Li T, Li D, Wei Q, Shi M, Xiang J, Gao R, Chen C, Xu ZX.

Neurobiol Dis. 2023 Jun 1;181:106114. doi: 10.1016/j.nbd.2023.106114. Epub 2023 Apr 5.

Non-Ceruloplasmin Copper Identifies a Subtype of Alzheimer's Disease (CuAD): Characterization of the Cognitive Profile and Case of a CuAD Patient Carrying an RGS7 Stop-Loss Variant

Squitti R, Catalli C, Gigante L, Marianetti M, Rosari M, Mariani S, Bucossi S, Mastromoro G, Ventriglia M, Simonelli I, Tondolo V, Singh P, Kumar A, Pal A, Rongioletti M.

Int J Mol Sci. 2023 Mar 28;24(7):6377. doi: 10.3390/ijms24076377.

Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review

Twarowski B, Herbet M.

Int J Mol Sci. 2023 Mar 30;24(7):6518. doi: 10.3390/ijms24076518.

The Senior Companion Program Plus (SCP Plus): Examining the Preliminary Effectiveness of a Lay Provider Program to Support African American Alzheimer's Disease and Related Dementias (ADRD) Caregivers

Xu L, Fields NL, Williams IC, Gaugler JE, Kunz-Lomelin A, Cipher DJ, Feinhals G.

Int J Environ Res Public Health. 2023 Apr 3;20(7):5380. doi: 10.3390/ijerph20075380.

Radiolabeled Chalcone Derivatives as Potential Radiotracers for β-Amyloid Plaques Imaging

Capponi PC, Mari M, Ferrari E, Asti M.

Molecules. 2023 Apr 4;28(7):3233. doi: 10.3390/molecules28073233.

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer's Dementia: A Systematic Review

Derks-Dijkman MW, Schaefer RS, Kessels RPC.

Neuropsychol Rev. 2024 Jun;34(2):455-477. doi: 10.1007/s11065-023-09585-4. Epub 2023 Apr 14.

Neural circuit changes in neurological disorders: Evidence from in vivo two-photon imaging

Xiong H, Tang F, Guo Y, Xu R, Lei P.

Ageing Res Rev. 2023 Jun;87:101933. doi: 10.1016/j.arr.2023.101933. Epub 2023 Apr 13.

Small Molecular Fluorescent Probes for Alzheimer's Disease Associated Active Species

Tang F, Wang K, Liu X, Zhang X, Zhou W, Mu Z, Zhang T, Shu W, Liu Y, Xiao H.

Chemistry. 2023 Jun 22;29(35):e202300592. doi: 10.1002/chem.202300592. Epub 2023 May 5.

Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: A systematic review and Bayesian network meta-analysis

Wei N, Liu H, Ye W, Xu S, Lu C, Dai A, Hou T, Zeng X, Wu J, Chen J.

CNS Neurosci Ther. 2023 Oct;29(10):2912-2924. doi: 10.1111/cns.14228. Epub 2023 Apr 23.

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR-SB

Jamalian S, Dolton M, Chanu P, Ramakrishnan V, Franco Y, Wildsmith K, Manser P, Teng E, Jin JY, Quartino A, Hsu JC; Alzheimer's Disease Neuroimaging Initiative.

CPT Pharmacometrics Syst Pharmacol. 2023 Jul;12(7):1029-1042. doi: 10.1002/psp4.12974. Epub 2023 May 2.

Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases

Mahmoudi R, Novella JL, Laurent-Badr S, Boulahrouz S, Tran D, Morrone I, Jaïdi Y.

Int J Mol Sci. 2023 Apr 7;24(8):6921. doi: 10.3390/ijms24086921.

Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms

Ma Y, Li Y, Yin R, Guo P, Lei N, Li G, Xiong L, Xie Y.

CNS Neurosci Ther. 2023 Aug;29(8):2045-2059. doi: 10.1111/cns.14234. Epub 2023 Apr 30.

Neuropathology of Anti-Amyloid-β Immunotherapy: A Case Report

Castellani RJ, Shanes ED, McCord M, Reish NJ, Flanagan ME, Mesulam MM, Jamshidi P.

J Alzheimers Dis. 2023;93(2):803-813. doi: 10.3233/JAD-221305.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias